Microwave adjuvant to radiotherapy and chemotherapy for advanced lymphoma.
Forty patients with intractable, recurrent Stage IV lymphoma were treated with applications of 434-MHz microwave radiation which were combined with small doses of cytotoxic drugs and/or supervoltage irradiation on an individual basis. Complete remission in 34 patients, and partial remission in four patients followed the treatment course; only two patients failed to improve. At the time of writing, 50% of these patients were alive; the average survival period being 47 months. The synergistic effect of the combination of microwave irradiation with conventional therapeutic agents is discussed.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008872:Microwaves / Q000627:therapeutic use*; D011882:Radiotherapy, High-Energy
D000970:Antineoplastic Agents